Chelsea Clinton's venture capital firm, Metrodora Ventures, led a $4 million pre-seed funding round for BioPhy, a startup that uses artificial intelligence to speed up drug development.
The Center City company founded by Wharton grads has two artificial intelligence-powered products to determine the success of new drugs and clinical trials, as well as help bring drugs to market more quickly.